Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atosiban for preterm labour.

Vassilis Tsatsaris1, Bruno Carbonne, Dominique Cabrol

  • 1Department of Obstetrics, Maternité Port-Royal, Hôpital Cochin, APHP, Université René Descartes, Paris, France. vassilis.tsatsaris@cch.ap-hop-paris.fr

Drugs
|February 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy-related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis.

British journal of clinical pharmacology·2026
Same author

Pregnancy-Related Complications in Primary Aldosteronism: A European Survey.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Impact of first-trimester preeclampsia screening on perinatal and maternal morbidity: the RANSPRE open multicenter randomized trial.

BMC pregnancy and childbirth·2026
Same author

[Medical termination of pregnancy for psychosocial distress: Overview of practices in France].

Gynecologie, obstetrique, fertilite & senologie·2026
Same author

Doppler ultrasound at 41 weeks: Pragmatic evidence, clinical relevance, and response to methodological considerations.

Journal of gynecology obstetrics and human reproduction·2026
Same author

Virtual reality to reduce anxiety and pain during invasive prenatal procedures.

European journal of obstetrics, gynecology, and reproductive biology·2025

Oxytocin antagonists, like atosiban, effectively reduce preterm labor compared to placebo. They offer similar efficacy to beta-agonists but with significantly fewer adverse effects, making them a preferred tocolytic treatment.

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology
  • Reproductive Medicine

Background:

  • Preterm labor is a significant concern in obstetrics.
  • Oxytocin antagonists are synthetic nonapeptides designed to inhibit uterine contractions.
  • Atosiban is a prominent oxytocin antagonist studied for tocolysis.

Purpose of the Study:

  • To evaluate the efficacy and safety of oxytocin antagonists, specifically atosiban, in managing preterm labor.
  • To compare atosiban with placebo and beta-adrenoceptor agonists in clinical trials.

Main Methods:

  • Conducted large-scale, placebo-controlled, and multicenter trials involving over 500 patients.
  • Compared atosiban's efficacy and adverse event profile against placebo and beta-adrenoceptor agonists.
  • Assessed pregnancy prolongation, maternal adverse effects, fetal well-being, and neonatal outcomes.

Related Experiment Videos

Main Results:

  • Atosiban significantly reduced premature deliveries over 7 days compared to placebo, with comparable adverse effects.
  • Efficacy for pregnancy prolongation was similar between atosiban and beta-agonists.
  • Atosiban demonstrated a superior safety profile, with fewer cardiovascular adverse effects and no observed fetal adverse effects.

Conclusions:

  • Oxytocin antagonists, particularly atosiban, show comparable effectiveness to beta-agonists in prolonging pregnancy.
  • Atosiban presents a safer alternative to beta-agonists, with a notable absence of significant adverse effects.
  • Oxytocin antagonists are validated tocolytics and may be the preferred treatment for preterm labor, especially in high-risk patients.